Picod A - Search Results

1

Acute pancreatitis in immunocompromised patients: beware of varicella zoster virus primo-infection.

Picod A, Corre E, Maury E, Duriez P, Hoyeau N, Coppo P. Picod A, et al. Clin Case Rep. 2017 Jun 22;5(8):1261-1263. doi: 10.1002/ccr3.1053. eCollection 2017 Aug. Clin Case Rep. 2017. PMID: 28781838 Free PMC article.

2

When targeted therapies alleviate the burden of TPE: The example of immune-mediated TTP.

Picod A, Coppo P. Picod A, et al. Transfus Apher Sci. 2019 Jun;58(3):273-277. doi: 10.1016/j.transci.2019.04.012. Epub 2019 Apr 19. Transfus Apher Sci. 2019. PMID: 31018909 Review.

3

Developments in the use of plasma exchange and adjunctive therapies to treat immune-mediated thrombotic thrombocytopenic purpura.

Picod A, Coppo P. Picod A, et al. Expert Rev Hematol. 2019 Jun;12(6):461-471. doi: 10.1080/17474086.2019.1619170. Epub 2019 May 23. Expert Rev Hematol. 2019. PMID: 31092093 Free article. Review.

4

Therapeutic plasma exchange in thrombotic thrombocytopenic purpura.

Picod A, Provôt F, Coppo P. Picod A, et al. Presse Med. 2019 Nov;48(11 Pt 2):319-327. doi: 10.1016/j.lpm.2019.08.024. Epub 2019 Nov 20. Presse Med. 2019. PMID: 31759790 Review.

5

Should all patients with immune-mediated thrombotic thrombocytopenic purpura receive caplacizumab?

Picod A, Veyradier A, Coppo P. Picod A, et al. J Thromb Haemost. 2021 Jan;19(1):58-67. doi: 10.1111/jth.15194. Epub 2020 Dec 17. J Thromb Haemost. 2021. PMID: 33236389 Free article. Review.

6

Thrombotic Thrombocytopenic Purpura: When Basic Science Meets Clinical Research.

Bécel G, Faict S, Picod A, Bouzid R, Veyradier A, Coppo P. Bécel G, et al. Among authors: picod a. Hamostaseologie. 2021 Aug;41(4):283-293. doi: 10.1055/a-1332-3066. Epub 2021 Feb 19. Hamostaseologie. 2021. PMID: 33607665 Free article.

7

Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination.

Picod A, Rebibou JM, Dossier A, Cador B, Ribes D, Vasco-Moynet C, Stephan C, Bellal M, Wynckel A, Poullin P, Péju E, Ricard L, Kahn JE, Bouzid R, Benhamou Y, Joly B, Veyradier A, Coppo P. Picod A, et al. Blood. 2022 Apr 21;139(16):2565-2569. doi: 10.1182/blood.2021015149. Blood. 2022. PMID: 35271696 Free PMC article. No abstract available.

8

Deregulated JAK3 mediates growth advantage and hemophagocytosis in extranodal nasal-type natural killer/T-cell lymphoma.

Picod A, Martino S, Cervera P, Manuceau G, Arca M, Wittner M, Zhang Y, Liang H, Beghi F, Solary E, Louache F, Coppo P. Picod A, et al. Haematologica. 2022 Sep 1;107(9):2218-2225. doi: 10.3324/haematol.2021.280349. Haematologica. 2022. PMID: 35511669 Free PMC article. No abstract available.

9

More on the use of frontline caplacizumab in immune-mediated thrombotic thrombocytopenic purpura.

Picod A, Benhamou Y, Bouzid R, Veyradier A, Coppo P. Picod A, et al. Blood Adv. 2023 Jun 27;7(12):2678-2680. doi: 10.1182/bloodadvances.2022009021. Blood Adv. 2023. PMID: 36260763 Free PMC article. No abstract available.

10

The Specificities of Thrombotic Thrombocytopenic Purpura at Extreme Ages: A Narrative Review.

Joseph A, Joly BS, Picod A, Veyradier A, Coppo P. Joseph A, et al. Among authors: picod a. J Clin Med. 2023 Apr 23;12(9):3068. doi: 10.3390/jcm12093068. J Clin Med. 2023. PMID: 37176509 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters